Static Chart Entera Bio Ltd.

Equities

Market Closed - Nasdaq Other stock markets 20:59:51 30/05/2024 BST			5-day change	1st Jan Change
2.31 ^USD	-4.94%		0.00%	+285.00%

05-15	Entera Bio Appoints Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member	CI
05-13	Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets for the Treatment of Hypoparathyroidism at ENDO 2024	CI

Duration

Period